SARS-CoV-2 infection U07.1
Conditions
Interventions
Group 1: Study participants will be asked to come to the clinic three times or alternatively may be visited at home by study personnel. At each visit, a blood sample will be collected and a questionna
Sponsors
Universita¨tsklinikum Heidelberg, Sektion Klinische Tropenmedizin
Eligibility
Sex/Gender
All
Age
5 Years to No maximum
Inclusion criteria
Inclusion criteria: a) Able to provide a blood sample b) Able to attend the Tropical Medicine clinic for blood draw or be available for a house visit c) In adults, the ability to provide fully informed consent d) Consent from a parent or guardian if the patient is under 18
Exclusion criteria
Exclusion criteria: a) Contraindication to venepuncture b) Age below 5 years of age c) Not able to provide informed consent
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Age-group specific prevalence of antibodies to SARS-CoV-2 among the general population of Heidelberg and the Rhein-Neckar region. | — |
Secondary
| Measure | Time frame |
|---|---|
| 1) Age-group specific cumulative incidence during the epidemic compared to the end of the epidemic (post-epidemic) or according to local COVID-19 epidemiology. 2) Association of risk factors / protective measures recorded on the questionnaire and evidence of SARS-CoV-2 infection (SARS-CoV-2 antibodies). 3) Proportion of asymptomatic / sub-clinical SARS-CoV-2 infections. | — |
Countries
Germany
Contacts
Public ContactClaudia Maria Denkinger
Universitätsklinikum Heidelberg, Sektion Klinische Tropenmedizin
Outcome results
None listed